Screener / SEC EDGAR /CIK 0001568651 /10-K filed Feb 13, 2026, compared with Feb 20, 2025 /Numbers from the XBRL of the 10-Ks
NYSE Financials · Health Insurance

Oscar Health, Inc. OSCR

Compare with peers Embed
FY2025 at a glance

Sales up 27.5%, free cash flow up to $1.1B

XBRL, from each 10-K
RevenueStatements
$11.7B from $9.2B in FY2024
FY2019FY2025
Net incomeStatements
-$443.2M from $25.4M in FY2024
FY2019FY2025
Free cash flowStatements
$1.1B from $950.3M in FY2024
FY2019FY2025
EPS (diluted)Statements
$-1.69 from $0.10 in FY2024
FY2019FY2025
Operating marginStatements
-3.4% from 0.6% in FY2024
FY2019FY2025
Total debtStatements
$430.1M from $299.6M in FY2024
FY2019FY2025

The latest figures

Price and key numbers

From EDGAR
All key numbers (39)
EPS (ttm)
2.25
Sales (ttm)
17.5B
Net income (ttm)
855.5M
Sales growth
+27.5%
EPS growth
to a loss
Sales Q/Q
+72.1%
Free cash flow
4.1B
Gross margin
-
Oper. margin
5.4%
Net margin
4.9%
FCF margin
23.7%
ROA
8.5%
R&D / sales
-
Dividend
-
Debt/Eq
0.19
Curr. ratio
1.14
Cash
4.5B
Op. cash flow (ttm)
4.2B
EBITDA
-367.5M
EBITDA margin
-3.1%
Net debt
-4.0B
Quick ratio
1.14
Interest cover
-22.52
FCF after stock pay
970.8M
Debt / FCF (years)
0.41
Oper. margin low 5y
-29.6%
Stock pay / sales
0.7%
Shares out.
346.5M
Shares Y/Y
-1.3%
Book / share
6.42
Cash / share
12.89
Sales / share
50.43
Asset turnover
1.75
Days sales out.
11
Sales 3Y CAGR
+43.4%
Sales 5Y CAGR
+90.8%
Employees
2,305
Sales / employee
7.6M

Hover or tap a number to see the XBRL line item and filing it comes from; click it to open that filing at SEC. What each number means. Looks wrong? Tell us.

Revenue and net income, FY2019 to FY2025

Each fiscal year from its own 10-K · XBRL

Revenue 11.7B +69.8% a year Net income -443.2M
FY2019 revenue 488.2M · Revenues, 0001568651-22-000011 FY2019 net income -261.2M · NetIncomeLoss, 0001568651-22-000011 488.2M FY2019 FY2020 revenue 462.8M · Revenues, 0001568651-23-000017 FY2020 net income -406.8M · NetIncomeLoss, 0001568651-23-000017 462.8M FY2020 FY2021 revenue 1.8B · Revenues, 0001568651-24-000006 FY2021 net income -572.6M · NetIncomeLoss, 0001568651-24-000006 1.8B FY2021 FY2022 revenue 4.0B · Revenues, 0001568651-25-000008 FY2022 net income -606.3M · NetIncomeLoss, 0001568651-25-000008 4.0B FY2022 FY2023 revenue 5.9B · Revenues, 0001568651-26-000011 FY2023 net income -270.7M · NetIncomeLoss, 0001568651-26-000011 5.9B FY2023 FY2024 revenue 9.2B · Revenues, 0001568651-26-000011 FY2024 net income 25.4M · NetIncomeLoss, 0001568651-26-000011 9.2B FY2024 FY2025 revenue 11.7B · Revenues, 0001568651-26-000011 FY2025 net income -443.2M · NetIncomeLoss, 0001568651-26-000011 11.7B FY2025

From XBRL in each 10-K. Hover a bar for the line item and filing. "A year" is the steady yearly growth from FY2019 to FY2025 (6 years).

Growth per share, FY2019 to FY2025

Earnings, book value and free cash flow for each diluted share · 10-K XBRL, every year linked to its filing

Average yearly growth
Book value per share -16.7% a year FY2021 $7.75 to FY2025 $3.73, 4 years
Free cash flow per share -10.8% a year FY2020 $7.13 to FY2025 $4.03, 5 years
Fiscal year toEPS (diluted)Book value / shareFree cash flow / share
Dec 31, 2025 -$1.69$3.73$4.03
Dec 31, 2024 $0.10$3.81$3.57
Dec 31, 2023 -$1.22$3.63-$1.34
Dec 31, 2022 -$2.85$4.19$1.65
Dec 31, 2021 -$3.20$7.75-$1.16
Dec 31, 2020 -$14.16-$44.28$7.13
Dec 31, 2019 -$9.06-$32.80-$6.64

Per share means per diluted weighted-average share of the same fiscal year (the count under diluted EPS, put on today's share count after a split). Book value is shareholders' equity at the year end, including any preferred stock; free cash flow is operating cash flow less capital spending. Each tile's rate is the steady yearly growth from the first to the last year it names: the window starts at the oldest year, up to ten years back, with a value above zero.

What the balance sheet holds, per share

Net current asset value and tangible book value, FY2025 · 10-K XBRL, no share price used

Net current asset value, FY2025, in dollars
  • + Current assets $4.6B
  • − All liabilities $5.3B
  • = Net current asset value -$731.3M
Per share, year by year
Tangible book value, FY2025, in dollars
  • + Shareholders' equity $977.6M
  • = Tangible book value $977.6M
Per share, year by year

Net current asset value is current assets minus all liabilities (the long-term ones too), so it is what would be left from the short-term assets after everything owed is paid; it is blank for a bank, which reports no current assets. Tangible book value is shareholders' equity minus goodwill and other intangible assets; equity includes any preferred stock. Both are divided by the diluted weighted-average share count of the same fiscal year. Red bars are amounts taken off, or a negative result.

OSCR against Financials peers

Among the 273 companies, the better end on the right. The band holds the middle half; the line is the median.

Ten years, side by side
Sales growth
+5.3%+20.1%
+27.5%41st of 242 · median +8.9%
Net margin
11.5%30.3%
4.9%214th of 240 · median 23.0%
Return on equity
8.9%19.7%
38.5%12th of 255 · median 12.9%
Free cash flow margin
16.4%39.6%
23.7%101st of 171 · median 27.4%
Debt / equity (less is better)
1.130.22
0.1941st of 189 · median 0.46
OSCR and the 5 peers closest in revenue
CompanyRevenue (ttm)Sales growthFYGross marginttmNet marginttmROEttmFCF marginttmDebt / equitylatest
OSCR Oscar Health, Inc.$17.5B +27.5%-4.9%38.5%23.7%0.19
AON Aon plc$17.7B +9.4%-22.2%38.9%18.5%2.78
RJF Raymond James Financial$17.0B +6.6%-13.6%18.2%8.5%0.07
PFG Principal Financial Group$16.6B -3.1%-11.9%16.7%-0.38
AFL Aflac$16.6B -9.3%-21.2%12.0%--
AJG Arthur J. Gallagher & Co.$16.4B +20.7%-10.4%7.1%-0.53
All 273 companies in the group

Where the return on equity comes from

DuPont: net margin × asset turnover × leverage, FY2025 against FY2021 · 10-K XBRL, year-end balances

Return on equity -45.3% FY2021: -41.3% net income ÷ equity
Net margin -3.8% FY2021: -31.1% profit per $ of sales: -443.2M ÷ 11.7B
Asset turnover 1.85× FY2021: 0.55× sales per $ of assets: 11.7B ÷ 6.3B
Leverage 6.47× FY2021: 2.39× assets per $ of equity: 6.3B ÷ 977.6M

The three parts multiply to the return on equity. A higher return from leverage alone means more debt or less equity (buybacks shrink equity), not a better business. Year-end balances as filed, not averages, so each number is one line of one 10-K; hover a box for its XBRL tags.

Profitability

  • Net margin below the peer median
    4.9% vs 23.0%
  • Return on equity above 15%
    38.5%
  • A profit in 1 of 7 years
Net margin, FY2019 to FY2025: -53.5% to -3.8%

Each tick is a fact with a fixed rule (on /methodology), not a score or advice. A check without the numbers it needs is left out.

Income statement, balance sheet and cash flow

Statements · XBRL, each 10-K and 10-Q

From EDGAR

OSCR's income statement, balance sheet and cash flow as reported to the SEC in XBRL, one column per fiscal year, the last 7. Hover a number to see the line item and filing it comes from. Where a company changed how it tags a line, the first tag it reported for that period is used. A number looks wrong? Tell us.

Revenue11.7B
FY2019: 488.2MFY2020: 462.8MFY2021: 1.8BFY2022: 4.0BFY2023: 5.9BFY2024: 9.2BFY2025: 11.7B FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Net income-443.2M
FY2019: -261.2MFY2020: -406.8MFY2021: -572.6MFY2022: -606.3MFY2023: -270.7MFY2024: 25.4MFY2025: -443.2M FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Free cash flow1.1B
FY2019: -191.4MFY2020: 208.7MFY2021: -207.6MFY2022: 351.3MFY2023: -297.7MFY2024: 950.3MFY2025: 1.1B FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Free cash flow after stock pay970.8M
FY2019: -224.9MFY2020: 172.8MFY2021: -293.9MFY2022: 239.0MFY2023: -457.4MFY2024: 840.5MFY2025: 970.8M FY2019FY2020FY2021FY2022FY2023FY2024FY2025
EPS (diluted)-1.69
FY2019: -9.06FY2020: -14.16FY2021: -3.20FY2022: -2.85FY2023: -1.22FY2024: 0.10FY2025: -1.69 FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Diluted shares262.4M
FY2019: 28.8MFY2020: 29.3MFY2021: 179.0MFY2022: 212.5MFY2023: 221.7MFY2024: 265.9MFY2025: 262.4M FY2019FY2020FY2021FY2022FY2023FY2024FY2025

Income statement

From EDGAR
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue488.2M462.8M1.8B4.0B5.9B9.2B11.7B
SG&A110.7M166.7M265.1M1.3B1.4B1.8B2.0B
Operating income-259.4M-402.3M-544.5M-589.9M-235.6M57.3M-396.4M
Interest expense03.5M4.7M22.6M24.6M23.7M17.6M
Pretax income-259.4M-405.8M-570.6M-610.1M-267.3M33.4M-437.3M
Income tax1.8M1.0M846K-523K3.3M7.3M5.6M
Net income-261.2M-406.8M-572.6M-606.3M-270.7M25.4M-443.2M
EPS (diluted)-9.06-14.16-3.20-2.85-1.220.10-1.69
Diluted shares28.8M29.3M179.0M212.5M221.7M265.9M262.4M
Depreciation & amortization6.9M11.3M14.6M15.3M30.7M32.1M28.9M
EBITDA-252.5M-391.0M-529.9M-574.6M-204.9M89.4M-367.5M
Operating margin-53.1%-86.9%-29.6%-14.9%-4.0%0.6%-3.4%
Net margin-53.5%-87.9%-31.1%-15.3%-4.6%0.3%-3.8%
Revenue growth--5.2%+297%+116%+47.9%+56.5%+27.5%
EPS growth------to a loss

Balance sheet

From EDGAR
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash336.6M826.3M1.1B1.6B1.9B1.5B2.8B
Short-term investments-366.4M587.1M1.4B689.8M624.5M1.2B
Receivables------362.7M
Current assets-1.9B2.3B4.1B3.1B2.8B4.6B
Property & equipment-35.8M46.6M59.9M61.9M66.8M88.3M
Total assets-2.3B3.3B4.5B3.6B4.8B6.3B
Current liabilities-1.7B1.9B3.3B2.4B3.5B4.9B
Total debt-142.5M0298.0M298.8M299.6M430.1M
Total liabilities-1.8B1.9B3.6B2.8B3.8B5.3B
Shareholders' equity-945.1M-1.3B1.4B890.4M804.0M1.0B977.6M
Retained earnings--1.4B-2.0B-2.6B-2.9B-2.9B-3.3B

Cash flow

From EDGAR
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow-165.4M222.7M-181.7M380.3M-272.2M978.2M1.1B
Capital spending26.0M14.0M25.9M29.0M25.6M27.9M36.4M
Free cash flow-191.4M208.7M-207.6M351.3M-297.7M950.3M1.1B
Stock-based pay (added back)33.6M35.9M86.3M112.3M159.7M109.8M87.7M
Free cash flow after stock pay-224.9M172.8M-293.9M239.0M-457.4M840.5M970.8M
Buybacks3.0M00----
Debt raised-147.0M0305.0M00410.0M
Debt repaid-0153.2M00--
Investing cash flow150.5M-344.7M-774.5M-226.5M577.2M-1.4B-241.1M
Financing cash flow-2.1M611.7M1.2B301.1M6.4M68.4M399.2M

Stock-based pay and leases

From EDGAR
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Stock-based pay (expense)33.6M35.9M86.3M112.3M159.7M109.8M87.7M
Stock-based pay / revenue6.9%7.8%4.7%2.8%2.7%1.2%0.7%
Operating lease cash paid--17.0M14.8M14.0M14.2M15.0M
Right-of-use assets--73.0M68.0M62.9M57.2M51.5M
Operating lease liabilities--91.7M85.0M81.0M74.2M68.7M

From SEC's XBRL company facts (data.sec.gov). EBITDA = operating income + depreciation and amortization; free cash flow = operating cash flow - capital spending; total debt = long-term debt (with its current part) + short-term borrowings. Stock-based pay and leases are shown as the company reports them; Tickdelta does not take them out of earnings or add leases to debt. Click a number to open the filing in SEC's Inline XBRL viewer, where you can click the same number to see how it is tagged. Values a company later revised show as revised; the Revised numbers tab lists the changes.

Sources

Every figure is from the company's XBRL filed with each 10-K and 10-Q (data.sec.gov). Hover a number for its line item; click it to open the filing.

Also

Company numbers: the figures the company reports beyond the statements. Peers: ten years, side by side.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/OSCR/export.csv") into a cell.

Next:Peers in numbers
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.